Johnson & Johnson hit with $8B jury verdict

Johnson & Johnson was hit with an $8 billion jury verdict over the marketing of antipsychotic drug Risperdal.

The plaintiff, Nicholas Murray, sued the company in 2013, alleging he grew breasts — a condition known as gynecomastia — after he started using Risperdal when he was 9 years old in 2003. He was using the drug to treat autism symptoms.

The suit accused J&J subsidiary Janssen Pharmaceuticals of improperly marketing the drug as a treatment for certain mental health disorders in children.

Read more from The New York Times.